Systolic Heart Failure: Clinical Trials

8 trials for Systolic Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 3 completed, 1 enrolling by invitation. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Unknown 4, Completed 3, Enrolling by invitation 1

Follow Systolic Heart Failure: new trials by email Literature Review of Systolic Heart Failure trials Research Report on Systolic Heart Failure

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure
Eplerenone, Spironolactone - Systolic Heart Failure
Phase 4Enrolling by invitationBispebjerg Hospital72002020-11-012023-02-01
Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure
Ferric carboxymaltose - Cardiac Failure, Systolic Heart Failure
Phase 4UnknownHospital Moinhos de Vento202019-08-302019-07-12
Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent Rehospitalizations
Levosimendan - Systolic Heart Failure
Phase 4UnknownCollegium Medicum w Bydgoszczy1002018-08-012018-12-05
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
Iron, Saline - Systolic Heart Failure, Iron Deficiency
Phase 4CompletedUniversitätsklinikum Hamburg-Eppendorf11052017-03-072025-01-28
Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism
Levothyroxine supplementation - Systolic Heart Failure, Sub-clinical Hypothyroidism
Phase 4UnknownUniversité de Sherbrooke402014-12-012014-12-16
Platelet Inhibition in Patients With Systolic Heart Failure
Prasugrel 10 mg daily x 2 weeks, Clopidogrel 75 mg daily x 2 weeks - Systolic Heart Failure
Phase 4CompletedUniversity of Nebraska302013-05-152023-10-10
Clinical Value of Heart Rate Variability Indexes to Predict Outcomes After Exercise Training in Chronic Heart Failure
Cardiac Rehabilitation - Heart Failure, Systolic Heart Failure
Phase 4CompletedUniversidad de la Republica402010-04-012016-09-16
Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy
Verapamil - Systolic Heart Failure, Myocardial Disease
Phase 4UnknownMedical University of Silesia1202006-01-012006-10-18

Narrower conditions

Heart Failure, Systolic (8)  ·  Heart Failure (4)  ·  Cardiomyopathies (1)  ·  Iron Deficiencies (1)  ·  Motor Activity (1)  ·  Systolic Murmurs (1)

Broader conditions

Cardiovascular Diseases (8)  ·  Heart Diseases (8)  ·  Heart Failure (4)  ·  Behavior (1)  ·  Heart Murmurs (1)  ·  Iron Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Cardiac Rehabilitation (1)  ·  Clopidogrel (1)  ·  Eplerenone (1)  ·  Exercise (1)  ·  Iron (1)  ·  Prasugrel Hydrochloride (1)  ·  Simendan (1)  ·  Sodium Chloride (1)  ·  Spironolactone (1)  ·  Verapamil (1)  ·  ferric carboxymaltose (1)

Sponsors

Bispebjerg Hospital (1)  ·  Collegium Medicum w Bydgoszczy (1)  ·  Hospital Moinhos de Vento (1)  ·  Medical University of Silesia (1)  ·  Universidad de la Republica (1)  ·  University of Nebraska (1)  ·  Universitätsklinikum Hamburg-Eppendorf (1)  ·  Université de Sherbrooke (1)

Countries

Poland (3)  ·  Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Portugal (1)  ·  Slovenia (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Carisi A Polanczyk, MD ScD (1)  ·  Jens Jakob Thune, MD, PhD (1)  ·  Luciano Giordani, MD (1)  ·  Luis Beck da Silva, MD ScD (1)  ·  Mahir Karaks, MD (1)  ·  Michel Nguyen, MD (1)  ·  Paul P Dobesh, PharmD (1)  ·  Paulo R Schvartzman, MD ScD (1)  ·  Roberto Ricca-Mallada, MD MSc (1)  ·  Romuald Wojnicz, MD, PhD (1)

Results publications

PMID 40159390, PMID 40300786, PMID 40740027